NYU Langone Health
New York, 10016, United States
NCT Number: NCT06222554
The objective of this study is to evaluate the feasibility of the MoveMend Health software program as an integrated supplement to traditional acute care/in-hospital occupational therapy for patients following liver and kidney transplants, as determined by recruitment rates, program completion, intervention adherence, safety incidence, and patient feedback on device/program performance.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10016, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Software-based therapeutic tool that offers gamified exercises and activities. The device is designed for deployment on tablets. The core purpose of the device is to augment patient engagement and participation in their own rehabilitation by providing additional therapeutic interventions between formal occupational therapy sessions.
Time frame: Up to Month 6 Post-Operation
Calculated by dividing the number of participants enrolled by the total number of patients contacted or screened.
Time frame: Up to Month 6 Post-Operation
Percentage of enrolled participants who complete the interventional program.
Time frame: Up to Month 6 Post-Operation
Measured by session duration and frequency, as recorded by the device. Participants will be classified as "adhering" or "not adhering."
Time frame: Up to Month 6 Post-Operation
Measured using data from participant's electronic medical record.
Time frame: Baseline, End of Hospital Stay (typically no more than 6 months post-operation)
12-item assessment of basic mobility of inpatients. Each item is rated on a Likert scale from 1-4. The raw score is the sum of responses, which is converted to a T-score. The total score is a T-score ranging from 0 to 100; higher scores indicate greater mobility.
Time frame: Baseline, End of Hospital Stay (typically no more than 6 months post-operation)
Measured as the percentage change in grip strength between the baseline assessment and the final assessment at discharge.
Time frame: Baseline, End of Hospital Stay (typically no more than 6 months post-operation)
Measured as the change in degrees of ROM at the shoulder and elbow as measured by a goniometer from baseline to discharge.
Time frame: Baseline, End of Hospital Stay (typically no more than 6 months post-operation)
The EQ-5D-5L is a self-reported health status questionnaire that consists of six questions used to calculate a health utility score for use in health economic analysis. There are two components to the EQ-5D-5L: a five-item health state profile that assesses mobility, self-care, usual activities, pain/discomfort, and anxiety/depression used to obtain an Index Utility Score, as well as a visual analogue scale (VAS) that measures health state. Overall scores range from 0 to 1, with low scores representing a higher level of dysfunction.
NYU Langone Health
Other
Pilot/Feasibility Study Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02057484
Kidney Transplant, Liver Transplant
Innsbruck, Austria
View Trial DetailsNCT03527238
Kidney Transplant, Liver Transplant
Los Angeles, California, United States
View Trial DetailsNCT02429869
HIV, Kidney Transplant
San Francisco, California, United States
View Trial DetailsNCT02182986
EBV-Related PTLD, Heart Transplant
Los Angeles, California, United States
View Trial Details